期刊
EXPERT OPINION ON DRUG DISCOVERY
卷 1, 期 7, 页码 635-652出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/17460441.1.7.635
关键词
efficacy; C-protein-coupled receptors; receptors; selective agonists; selective antagonists
Before the direct measurement of G-protein-coupled receptor (GPCR) behaviour was possible, all GPCR ligand efficacy was assumed to be linear, that is, to emanate only from physiological activation of the receptor as observed through tissue response. Subsequent advances in technology have enabled the observation of the effects unrelated to GPCR response (e.g., receptor phosphorylation and internalisation), as well as separate response pathways independent of G protein activation (i.e., beta-arrestin extracellular signal-related kinase [ERK1/2] activation). These increased vantage points have revealed ligands that have efficacies for some, but not all, GPCR behaviours; this is referred to as collateral efficacy. These ideas are explored, with examples, in the context of possibly more focused therapeutic application of agonists and antagonists.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据